XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 37 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $55,000 | -95.3% | 22,500 | -92.2% | 0.00% | – |
| Q2 2021 | $1,168,000 | -7.0% | 286,803 | +3.0% | 0.00% | – |
| Q1 2021 | $1,256,000 | +21.1% | 278,575 | +32.2% | 0.00% | – |
| Q4 2020 | $1,037,000 | +4.1% | 210,655 | +25.4% | 0.00% | – |
| Q3 2020 | $996,000 | +164.2% | 167,951 | +18.3% | 0.00% | – |
| Q2 2020 | $377,000 | +35.6% | 141,914 | -0.6% | 0.00% | – |
| Q1 2020 | $278,000 | -10.0% | 142,710 | +225.1% | 0.00% | – |
| Q4 2019 | $309,000 | -24.4% | 43,903 | +5.6% | 0.00% | – |
| Q3 2019 | $409,000 | +79.4% | 41,576 | +108.2% | 0.00% | – |
| Q2 2019 | $228,000 | +4.1% | 19,973 | -8.4% | 0.00% | – |
| Q1 2019 | $219,000 | +72.4% | 21,808 | +192.0% | 0.00% | – |
| Q4 2018 | $127,000 | +13.4% | 7,468 | +17.6% | 0.00% | – |
| Q3 2018 | $112,000 | – | 6,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |